Novo and Lilly outline plans to mitigate disruptions from US port strikes

Novo Nordisk and Eli Lilly, whose obesity drugs are some of the most in-demand drugs in the US, have drafted plans to avoid supply disruptions …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Viking’s $350M offering; Baker Brothers leads another PIPE

Plus, news about Applied Therapeutics, Beam Therapeutics, Janux Therapeutics and more: Viking Therapeutics sells off $350M of stock following positive obesity drug data: On the

February 29, 2024

New trial shows felzartamab reduces proteinuria in IgA nephropathy patients

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface.

October 27, 2024

Learning from loss: US covid-19 experience charts path for future public health

Ahead of the 2024 US presidential election, The BMJ today launches a forward-looking series that highlights the lessons that can be learned from the US’s

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.